Torrey Pines Medicine Raises Funding For Ultra-Long-Acting Metabolic Therapies
By Amit Chowdhry ● Jul 30, 2026
Torrey Pines Medicine has raised tens of millions of renminbi in an angel financing round to advance ultra-long-acting peptide medicines for obesity, type 2 diabetes and other metabolic diseases. The round was led by Lotus Lake Ventures, with participation from Stars Capital, Tainuo Capital, Blue Ocean Capital and entrepreneur Yousheng Shen. The company will use the proceeds to support corporate development, prepare its TPM004 program for an investigational new drug submission and Phase 1 clinical testing, and expand its PepTetris peptide discovery platform.